These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 4675174)

  • 1. Haloperidol: fifteen years of clinical experience.
    Ayd FJ
    Dis Nerv Syst; 1972 Jul; 33(7):459-69. PubMed ID: 4675174
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of outpatients with high doses of haloperidol].
    Shopsin B; Kline N
    Acta Psiquiatr Psicol Am Lat; 1981 Jul; 27(3):236-42. PubMed ID: 7348083
    [No Abstract]   [Full Text] [Related]  

  • 3. Haloperidol update: 1975.
    Ayd FJ
    Proc R Soc Med; 1976; 69 suppl 1(Suppl 1):14-22. PubMed ID: 1019142
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term effects of haloperidol.
    Man PL
    Dis Nerv Syst; 1973 Feb; 34(2):113-8. PubMed ID: 4267586
    [No Abstract]   [Full Text] [Related]  

  • 5. Haloperidol: a quarter century of experience.
    Settle EC; Ayd FJ
    J Clin Psychiatry; 1983 Dec; 44(12):440-8. PubMed ID: 6418723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haloperidol in overt ambulatory schizophrenics.
    Darling HF
    Dis Nerv Syst; 1973; 34(7):364-7. PubMed ID: 4782293
    [No Abstract]   [Full Text] [Related]  

  • 7. To the incompatibility of haloperidol with lithium salts.
    Marhold J; Zimanová J; Lachman M; Král J; Vojtĕchovský M
    Act Nerv Super (Praha); 1974 Aug; 16(3):199-200. PubMed ID: 4420744
    [No Abstract]   [Full Text] [Related]  

  • 8. Adverse reactions in treatment with lithium carbonate and haloperidol.
    Baastrup PC; Hollnagel P; Sorensen R; Schou M
    JAMA; 1976 Dec; 236(23):2645-6. PubMed ID: 1036539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacological studies with haloperidol.
    Dunlop E
    J New Drugs; 1966; 6(4):243-6. PubMed ID: 5968054
    [No Abstract]   [Full Text] [Related]  

  • 10. Overview: efficacy and safety of the rapid neuroleptization method with injectable haloperidol.
    Donlon PT; Hopkin J; Tupin JP
    Am J Psychiatry; 1979 Mar; 136(3):273-8. PubMed ID: 369395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haloperidol and the butyrophenones.
    Ban TA
    Psychosomatics; 1973; 14(5):286-97. PubMed ID: 4604517
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of tardive dyskinesia. II. Short-term efficacy of dopamine-blocking agents haloperidol and thiopropazate.
    Kazamatsuri H; Chien C; Cole JO
    Arch Gen Psychiatry; 1972 Jul; 27(1):100-3. PubMed ID: 4555826
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term treatment of tardive dyskinesia with haloperidol and tetrabenazine.
    Kazamatsuri H; Chien CP; Cole JO
    Am J Psychiatry; 1973 Apr; 130(4):479-83. PubMed ID: 4570750
    [No Abstract]   [Full Text] [Related]  

  • 14. [Successful electroconvulsive therapy in a pregnant woman with neuroleptic malignant syndrome].
    Verwiel JM; Verwey B; Heinis C; Thies JE; Bosch FH
    Ned Tijdschr Geneeskd; 1994 Jan; 138(4):196-9. PubMed ID: 8107921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dexetimide (R 16470) in the control of neuroleptic-induced extrapyramidal side-effects. Its prophylactic value and duration of action.
    Huygens H; Vereecken JL; Tanghe A
    Psychiatr Neurol Neurochir; 1973; 76(4):251-9. PubMed ID: 4581374
    [No Abstract]   [Full Text] [Related]  

  • 16. Neuroleptics and the corpus striatum: clinical implications.
    Stimmel GL
    Dis Nerv Syst; 1976 Apr; 37(4):219-24. PubMed ID: 1253676
    [No Abstract]   [Full Text] [Related]  

  • 17. [On the position of the butyrophenone derivative Haloperidol in psychiatric treatment].
    Greger J; Glitschka A; Müller K
    Psychiatr Neurol Med Psychol (Leipz); 1968 Jun; 20(7):241-52. PubMed ID: 5731879
    [No Abstract]   [Full Text] [Related]  

  • 18. Decreased extrapyramidal symptoms with intravenous haloperidol.
    Menza MA; Murray GB; Holmes VF; Rafuls WA
    J Clin Psychiatry; 1987 Jul; 48(7):278-80. PubMed ID: 3597329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extrapyramidal side effects and oral haloperidol: an analysis of explanatory patient and treatment characteristics.
    Moleman P; Schmitz PJ; Ladee GA
    J Clin Psychiatry; 1982 Dec; 43(12):492-6. PubMed ID: 7161250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of antipsychotics in children and adolescents.
    Findling RL; Steiner H; Weller EB
    J Clin Psychiatry; 2005; 66 Suppl 7():29-40. PubMed ID: 16124839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.